Minami S, Yotsuji A, Nakashima H, Watanabe Y, Yasuda T, Saikawa I
Jpn J Antibiot. 1983 Dec;36(12):3444-9.
The in vivo antibacterial activity of cefoperazone (CPZ) against systemic infections was studied in comparison with that of cefotiam (CTM) using beta-lactamase non-producing bacteria and producing bacteria. In vitro antibacterial activity of CPZ against Gram-positive bacteria was slightly inferior to that of CTM, but there was no significant difference between their in vivo activities. On the other hand, the therapeutic effect of CPZ against Gram-negative bacteria was nearly parallel to in vitro antibacterial activity and particularly was superior to that of CTM against cephalosporinase (CSase) producing bacteria. The ascitic levels of CPZ in mice infected with CSase producing bacteria were persisted longer, but those of CTM disappeared quickly after administration. This result appeared to reflect on the therapeutic effects of both drugs.
以不产β-内酰胺酶的细菌和产β-内酰胺酶的细菌为研究对象,比较了头孢哌酮(CPZ)和头孢替安(CTM)对全身感染的体内抗菌活性。CPZ对革兰氏阳性菌的体外抗菌活性略低于CTM,但二者的体内活性无显著差异。另一方面,CPZ对革兰氏阴性菌的治疗效果与体外抗菌活性几乎平行,尤其对产头孢菌素酶(CSase)的细菌,其治疗效果优于CTM。感染产CSase细菌的小鼠腹腔内CPZ水平持续时间更长,而CTM的水平在给药后迅速消失。这一结果似乎反映了两种药物的治疗效果。